ReNeuroCell Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

ReNeuroCell Therapeutics General Information

Description

Developer of advanced patient-tailored treatments intended for neural tissue injury. The company uses proprietary technologies to develop novel treatments for central nervous system injuries, consisting of potent neural cell progenitors grown inside bioactive biomaterials, enabling people to get precise biofabrication.

Contact Information

Website
www.reneurocell.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • North Plastira 100
  • Science and Technology Park of Crete
  • Heraklion, 700 13
  • Greece
+30 281
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • North Plastira 100
  • Science and Technology Park of Crete
  • Heraklion, 700 13
  • Greece
+30 281

ReNeuroCell Therapeutics Timeline

20252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ReNeuroCell Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 23-Apr-2026 Completed Startup
2. Accelerator/Incubator 27-May-2024 Completed Startup
1. University Spin-Out 01-Jan-2024 Completed Startup
To view ReNeuroCell Therapeutics’s complete valuation and funding history, request access »

ReNeuroCell Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator
StartSmart South Eastern Europe Accelerator/Incubator Minority
Foundation for Research and Technology - Hellas Corporation
University of Crete University
To view ReNeuroCell Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

ReNeuroCell Therapeutics FAQs

  • When was ReNeuroCell Therapeutics founded?

    ReNeuroCell Therapeutics was founded in 2024.

  • Where is ReNeuroCell Therapeutics headquartered?

    ReNeuroCell Therapeutics is headquartered in Heraklion, Greece.

  • What industry is ReNeuroCell Therapeutics in?

    ReNeuroCell Therapeutics’s primary industry is Biotechnology.

  • Is ReNeuroCell Therapeutics a private or public company?

    ReNeuroCell Therapeutics is a Private company.

  • What is ReNeuroCell Therapeutics’s current revenue?

    The current revenue for ReNeuroCell Therapeutics is .

  • How much funding has ReNeuroCell Therapeutics raised over time?

    ReNeuroCell Therapeutics has raised $3.24K.

  • Who are ReNeuroCell Therapeutics’s investors?

    European Innovation Council, StartSmart South Eastern Europe, Foundation for Research and Technology - Hellas, and University of Crete have invested in ReNeuroCell Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process